Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01607892
Recruitment Status : Completed
First Posted : May 30, 2012
Last Update Posted : March 2, 2018
Information provided by (Responsible Party):
Karyopharm Therapeutics Inc

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2016
  Study Completion Date : June 2016
Publications automatically indexed to this study by Identifier (NCT Number):